Clinical Trials Sponsored by Point Therapeutics
Total 6641 results
-
Pendulum TherapeuticsTerminatedType 2 Diabetes MellitusIreland
-
Veralox TherapeuticsCompletedSafety and Tolerability in Healthy VolunteersUnited States
-
Syndesi TherapeuticsTerminatedCognitive DeclineUnited Kingdom, Germany
-
Elevar TherapeuticsCompleted
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
HiFiBiO TherapeuticsCompleted
-
Cartesian TherapeuticsCompleted
-
HiFiBiO TherapeuticsCompleted
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Corcept TherapeuticsCompleted
-
Sage TherapeuticsCompletedSevere Postpartum DepressionUnited States
-
Allergy TherapeuticsCompleted
-
PTC TherapeuticsCompleted
-
Cadent TherapeuticsCompleted
-
Tarveda TherapeuticsCompletedNeuroendocrine Tumors | Neuroendocrine Carcinoma | Carcinoma, Small Cell LungUnited States, United Kingdom
-
Aptevo TherapeuticsWithdrawn
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Alaunos TherapeuticsTerminatedDiffuse Intrinsic Pontine Glioma | Pediatric Brain TumorUnited States
-
TR TherapeuticsCompleted
-
Heron TherapeuticsCompletedPostoperative PainUnited States
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompleted
-
Alaunos TherapeuticsCompletedGlioblastoma Multiforme | Anaplastic OligoastrocytomaUnited States
-
Nektar TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Atacama TherapeuticsActive, not recruitingHyperhidrosis | Palmar HyperhidrosisUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
AKARI TherapeuticsTerminatedParoxysmal Nocturnal HemoglobinuriaPoland
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Aptevo TherapeuticsTerminatedPsoriasis | Ulcerative ColitisAustralia
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States, Canada, India, United Kingdom, Spain, Israel, Australia, Belgium, France, Austria, China, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Sweden
-
vTv TherapeuticsTerminatedAlzheimer's DiseaseUnited States, Australia, Canada, South Africa, United Kingdom, Ireland, New Zealand
-
Cyclerion TherapeuticsTerminated
-
Cadent TherapeuticsWithdrawnSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...United States
-
Aelix TherapeuticsCompleted
-
VLP TherapeuticsCompletedMalaria,FalciparumUnited States
-
Mersana TherapeuticsCompletedAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Nonsmall Cell Lung CancerUnited States
-
Akebia TherapeuticsTerminatedAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States
-
Allergy TherapeuticsCompletedSeasonal Allergic RhinitisUnited States
-
MC2 TherapeuticsCompleted
-
United TherapeuticsCompletedSmall Cell Lung CancerUnited States, Canada, Spain, Australia, Korea, Republic of, France, United Kingdom, Thailand, Malaysia, Hungary, Poland, Taiwan, Philippines, Hong Kong, Lithuania, Georgia, Bulgaria, India, Italy, Romania, Russian Federation, Slo... and more
-
Allergy TherapeuticsTerminated
-
Shield TherapeuticsUnknownFour-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy VolunteersAnemia, Iron DeficiencyUnited States
-
Shield TherapeuticsCompletedAnemia, Iron-Deficiency | Crohn's Disease | Inflammatory Bowel DiseaseUnited States, France, Germany, Spain, Belgium, Hungary
-
Shield TherapeuticsCompletedRenal Insufficiency, Chronic | Iron-Deficiency AnemiaUnited States